Practice question

Answer the question and get instant feedback.

Moderate"KDIGO supports adding a nonsteroidal MRA (finerenone) in T2D with albuminuric CKD on ACEi/ARB and SGLT2 inhibitor to reduce CV and kidney outcomes. Thiazides/CCBs (BCKD stage 3 with persistent albuminuria despite ACE inhibitor and SGLT2 inhibitor"nephrology"

A 64-year-old with T2D, CKD stage 3 and persistent albuminuria despite ACE inhibitor and SGLT2 inhibitor asks about additional kidney-protective therapy. Which is recommended?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.